International Collaborative Ovarian Neoplasm trial 1: A randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer

International Collaborative Ovarian Neoplasm (ICON) collaborators (2003) International Collaborative Ovarian Neoplasm trial 1: A randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer. Journal of the National Cancer Institute, 95 (2). pp. 125-132. ISSN 0027-8874

Full text not available from this repository.

Abstract

The question of whether platinum-based adjuvant chemotherapy can improve outcomes in patients with early-stage epithelial ovarian cancer is an important one. We carried out a multicenter, open randomized trial to determine whether adjuvant chemotherapy would improve overall survival and prolong recurrence-free survival in women with early-stage epithelial ovarian cancer.

Item Type: Article
Uncontrolled Keywords: aged,aged, 80 and over,antineoplastic agents,antineoplastic combined chemotherapy protocols,carboplatin,carcinoma,chemotherapy, adjuvant,cisplatin,confidence intervals,disease-free survival,drug administration schedule,female,humans,international cooperation,middle aged,neoplasm staging,observation,odds ratio,ovarian neoplasms,survival analysis,treatment outcome,sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups: Faculty of Medicine and Health Sciences > Research Groups > Norwich Clinical Trials Unit
Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health
Faculty of Medicine and Health Sciences > Research Groups > Health Services and Primary Care
Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023)
Depositing User: Pure Connector
Date Deposited: 07 Jul 2014 12:08
Last Modified: 29 Aug 2023 13:30
URI: https://ueaeprints.uea.ac.uk/id/eprint/48058
DOI: 10.1093/jnci/95.2.125

Actions (login required)

View Item View Item